U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

::::::

Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee

Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Announcement
Agenda
…Under Topic 1, the committee will meet in open session to discuss the Emergency Use Authorization (EUA) of the ModernaTX Inc. COVID-19 vaccine for the administration of an additional dose, or “booster” dose, following completion of the primary series, to individuals 18 years of age and older. On October 15, 2021, under Topic II, the committee will meet in open session to discuss the Emergency Use Authorization (EUA) of the Janssen Biotech Inc. COVID-19 vaccine for the administration of an additional dose, or “booster” dose, to individuals 18 years of age and older.

 

::::::

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Statement by President Joe Biden on 700,000 American Deaths from COVID-⁠19
October 02, 2021 • Statements and Releases

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
October 01, 2021 • Press Briefings

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
September 28, 2021 • Press Briefings

President Biden Announces Intent to Nominate Dr. John N. Nkengasong as Ambassador-at-Large and Coordinator of United States Government Activities to Combat HIV/AIDS Globally
September 27, 2021 • Statements and Releases

Remarks by President Biden While Receiving a COVID-⁠19 Booster Shot
September 27, 2021 • Speeches and Remarks